1
Resistance to anti-cancer therapeutics targeting receptor tyrosine kinases and downstream pathways /
Group Author:
Published: Springer,
Publication Dates: [2018]
Call Number: R730.53/R433
;
Published: Springer,
Publication Dates: [2018]
Call Number: R730.53/R433